Frontiers | Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study
www.frontiersin.org
Specific types are most commonly treated with sulfonylurea, particularly those identified as HNF4A-MODY and HNF1A-MODY. HNF1B-MODY is another type that is most frequently managed with insulin therapy but lacks a defined precision treatment. a renal cyst, and hypomagnesemia.
1 Users
0 Comments
3 Highlights
0 Notes
Top Highlights
- Specific types are most commonly treated with sulfonylurea, particularly those identified as HNF4A-MODY and HNF1A-MODY.
- HNF1B-MODY is another type that is most frequently managed with insulin therapy but lacks a defined precision treatment.
- a renal cyst, and hypomagnesemia.
Domain
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.